Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara Tolusso

Showing results (11-20 of 94) with videos related to

Pageof 10
Sort By:
Frontiers in Medicine|April 10, 2023
The forgotten key players in rheumatoid arthritis: IL-8 and IL-17 - Unmet needs and therapeutic perspectivesElisa Gremese, Barbara Tolusso, Dario Bruno, et al.
Mediators of Inflammation|December 5, 2017
The Role of High-Mobility Group Box-1 and Its Crosstalk with Microbiome in Rheumatoid ArthritisFederico Biscetti, Andrea Flex, Stefano Alivernini, et al.
The Journal of Rheumatology|September 18, 2002
Tumor necrosis factor-alpha receptor II polymorphism in patients from southern Europe with mild-moderate and severe rheumatoid arthritisMartina Fabris, Barbara Tolusso, Emma Di Poi, et al.
Arthritis Research & Therapy|February 5, 2016
Tapering and discontinuation of TNF-α blockers without disease relapse using ultrasonography as a tool to identify patients with rheumatoid arthritis in clinical and histological remissionStefano Alivernini, Giusy Peluso, Anna Laura Fedele, et al.
Annals of the Rheumatic Diseases|April 26, 2011
Very early rheumatoid arthritis is the major predictor of major outcomes: clinical ACR remission and radiographic non-progressionSilvia Bosello, Anna Laura Fedele, Giusy Peluso, et al.
The Journal of Rheumatology|September 18, 2012
ZAP-70+ B cell subset influences response to B cell depletion therapy and early repopulation in rheumatoid arthritisElisa Gremese, Barbara Tolusso, Anna Laura Fedele, et al.
Pharmacological Research|October 2, 2019
The B side of rheumatoid arthritis pathogenesisStefano Alivernini, Barbara Tolusso, Anna Laura Fedele, et al.
Molecular Medicine (Cambridge, Mass.)|August 5, 2010
Interleukin-1β and interleukin-6 in arthritis animal models: roles in the early phase of transition from acute to chronic inflammation and relevance for human rheumatoid arthritisGianfranco Ferraccioli, Luisa Bracci-Laudiero, Stefano Alivernini, et al.
Autoimmunity Reviews|September 14, 2017
Is ACPA positivity the main driver for rheumatoid arthritis treatment? Pros and consStefano Alivernini, Mauro Galeazzi, Hagit Peleg, et al.
Autoimmunity Reviews|May 7, 2011
B cells in systemic sclerosis: a possible target for therapySilvia Bosello, Giacomo De Luca, Barbara Tolusso, et al.
Pageof 10

Showing results (11-20 of 94) with videos related to

Sort By:
Pageof 10
Frontiers in Medicine|April 10, 2023
The forgotten key players in rheumatoid arthritis: IL-8 and IL-17 - Unmet needs and therapeutic perspectivesElisa Gremese, Barbara Tolusso, Dario Bruno, et al.
Mediators of Inflammation|December 5, 2017
The Role of High-Mobility Group Box-1 and Its Crosstalk with Microbiome in Rheumatoid ArthritisFederico Biscetti, Andrea Flex, Stefano Alivernini, et al.
The Journal of Rheumatology|September 18, 2002
Tumor necrosis factor-alpha receptor II polymorphism in patients from southern Europe with mild-moderate and severe rheumatoid arthritisMartina Fabris, Barbara Tolusso, Emma Di Poi, et al.
Arthritis Research & Therapy|February 5, 2016
Tapering and discontinuation of TNF-α blockers without disease relapse using ultrasonography as a tool to identify patients with rheumatoid arthritis in clinical and histological remissionStefano Alivernini, Giusy Peluso, Anna Laura Fedele, et al.
Annals of the Rheumatic Diseases|April 26, 2011
Very early rheumatoid arthritis is the major predictor of major outcomes: clinical ACR remission and radiographic non-progressionSilvia Bosello, Anna Laura Fedele, Giusy Peluso, et al.
The Journal of Rheumatology|September 18, 2012
ZAP-70+ B cell subset influences response to B cell depletion therapy and early repopulation in rheumatoid arthritisElisa Gremese, Barbara Tolusso, Anna Laura Fedele, et al.
Pharmacological Research|October 2, 2019
The B side of rheumatoid arthritis pathogenesisStefano Alivernini, Barbara Tolusso, Anna Laura Fedele, et al.
Molecular Medicine (Cambridge, Mass.)|August 5, 2010
Interleukin-1β and interleukin-6 in arthritis animal models: roles in the early phase of transition from acute to chronic inflammation and relevance for human rheumatoid arthritisGianfranco Ferraccioli, Luisa Bracci-Laudiero, Stefano Alivernini, et al.
Autoimmunity Reviews|September 14, 2017
Is ACPA positivity the main driver for rheumatoid arthritis treatment? Pros and consStefano Alivernini, Mauro Galeazzi, Hagit Peleg, et al.
Autoimmunity Reviews|May 7, 2011
B cells in systemic sclerosis: a possible target for therapySilvia Bosello, Giacomo De Luca, Barbara Tolusso, et al.
Pageof 10